Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: A review
Chagas disease, leishmaniasis and schistosomiasis are neglected diseases (NDs) and are
a considerable global challenge. Despite the huge number of people infected, NDs do not …
a considerable global challenge. Despite the huge number of people infected, NDs do not …
Current advances in drug discovery for Chagas disease
Chagas disease, also known as American trypanosomiasis, is one of the 17 neglected
tropical diseases (NTDs) according to World Health Organization. It is estimated that 8–10 …
tropical diseases (NTDs) according to World Health Organization. It is estimated that 8–10 …
Nitro-group-containing drugs
K Nepali, HY Lee, JP Liou - Journal of medicinal chemistry, 2018 - ACS Publications
The nitro group is considered to be a versatile and unique functional group in medicinal
chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues …
chemistry. Despite a long history of use in therapeutics, the nitro group has toxicity issues …
Synthesis and Biophysical and Biological Studies of N-Phenylbenzamide Derivatives Targeting Kinetoplastid Parasites
JJ Nué-Martinez, D Cisneros… - Journal of Medicinal …, 2023 - ACS Publications
The AT-rich mitochondrial DNA (kDNA) of trypanosomatid parasites is a target of DNA minor
groove binders. We report the synthesis, antiprotozoal screening, and SAR studies of three …
groove binders. We report the synthesis, antiprotozoal screening, and SAR studies of three …
Current and future prospects of nitro-compounds as drugs for trypanosomiasis and leishmaniasis
S Patterson, AH Fairlamb - Current medicinal chemistry, 2019 - benthamdirect.com
Interest in nitroheterocyclic drugs for the treatment of infectious diseases has undergone a
resurgence in recent years. Here we review the current status of monocyclic and bicyclic …
resurgence in recent years. Here we review the current status of monocyclic and bicyclic …
Nitro compounds against trypanosomatidae parasites: Heroes or villains?
PF da Silva Santos-Júnior, LR Silva… - Bioorganic & Medicinal …, 2022 - Elsevier
Abstract Chagas disease and Human African trypanosomiasis (HAT) are caused by
Trypanosoma cruzi, T. brucei rhodesiense or T. b. gambiense parasites, respectively; while …
Trypanosoma cruzi, T. brucei rhodesiense or T. b. gambiense parasites, respectively; while …
Thio- and selenosemicarbazones as antiprotozoal agents against Trypanosoma cruzi and Trichomonas vaginalis
Herein, we report the preparation of a panel of Schiff bases analogues as antiprotozoal
agents by modification of the stereoelectronic effects of the substituents on N-1 and N-4 and …
agents by modification of the stereoelectronic effects of the substituents on N-1 and N-4 and …
Dearomative spiroannulation of indoles enabled by the diaza-[1, 2]-Wittig rearrangement
C Luo, CY Guan, ZY Li, B Gao, GJ Mei - Organic Chemistry Frontiers, 2024 - pubs.rsc.org
The first diaza-[1, 2]-Wittig rearrangement-enabled dearomative spiroannulation (DSA)
reaction of indoles is reported. In contrast to the previous dearomatization approaches using …
reaction of indoles is reported. In contrast to the previous dearomatization approaches using …
[HTML][HTML] Novel Treatment Approaches to Combat Trichomoniasis, a Neglected and Sexually Transmitted Infection Caused by Trichomonas vaginalis: Translational …
The multistep translational science behind new drugs comprehends the entire process
through laboratory, clinical, and community observations turned into health interventions …
through laboratory, clinical, and community observations turned into health interventions …
Recent developments in anti-Trichomonas research: An update review
Trichomonas vaginalis is a major non-viral sexually-transmitted infection resulted into
serious obstetrical and gynecological troubles. The increasing resistance to nitroimidazole …
serious obstetrical and gynecological troubles. The increasing resistance to nitroimidazole …